Comparing Hercessi vs Kanjinti
| Hercessi (trastuzumab) | Kanjinti (trastuzumab) |
|
|---|
| Hercessi (trastuzumab) | Kanjinti (trastuzumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer. Hercessi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer. Kanjinti may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
Breast Cancer, Adjuvant
Esophageal Carcinoma
|
|||||||||||||||
| More about Hercessi (trastuzumab) | More about Kanjinti (trastuzumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Hercessi side effects |
View all Kanjinti side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Hercessi prices |
View all Kanjinti prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other trastuzumab brands include: Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera | Other trastuzumab brands include: Herceptin, Hercessi, Herzuma, Ogivri, Ontruzant, Trazimera | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
924 hours |
924 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 187 drugs are known to interact with Hercessi:
|
A total of 187 drugs are known to interact with Kanjinti:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
April 25, 2024 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.